SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px
Organisation › Details

Abzena plc (AIM: ABZA)

Abzena provides proprietary technologies and complementary services to enable the development of better biopharmaceuticals. The Group comprises PolyTherics and Antitope which have established a broad suite of services and technologies that are designed to improve the chances of successful development of antibodies and proteins with enhanced therapeutic benefits. Antitope provides immunogenicity assessment, protein engineering to create humanized antibodies and deimmunised therapeutic proteins, and cell line development for manufacture. PolyTherics specializes in proprietary site-specific conjugation technologies for antibody drug conjugate development and solutions for optimization of the therapeutic properties of biopharmaceuticals. The Group has built a global customer base over the past decade which includes the majority of the top 20 biopharmaceutical companies, many large and small biotech companies, and academic groups. Abzena is quoted on the AIM segment of the London Stock Exchange under the symbol ABZA. *


Period Start 2014-07-10 renamed
  Group Abzena (Group)
  Predecessor Abzena Ltd.
Products Industry biopharmaceutical
  Industry 2 drug development
Persons Person Burt, John (Abzena 201405– CEO before Antitope + PolyTherics + Thiakis)
  Person 2 Smith, Julian (PolyTherics 201309– CFO before Imperial Innovations + RadioScape)
Region Region London, Greater London
  Country United Kingdom (GB)
Basic data Employees D: 101 to 500 (2018-03-30)
  Currency GBP
  Annual sales 21,950,000 (revenues, consolidated (2017/18) 2018-03-31)
  Profit -14,161,000 (2018-03-31)
  Cash 6,785,000 (2013-03-31)
    * Document for �About Section�: Abzena plc. (6/8/15). "Press Release: Results for the Year Ended 31 March 2015". Cambridge, UK.
Record changed: 2018-10-31


Picture [LSUS] – The Business Web Portal 600x60px

More documents for Abzena (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top